Armenian govt slams drug price rises
In Armenia, the State Revenues Minister, Andranik Manukyan, hascriticized drug wholesalers and retailers for increasing their prices 35%-40% following the imposition of value-added tax on drugs at a rate of 20% at the start of the year, reports the Snark news agency.
Retailers say they were forced to raise their prices substantially due to the higher prices charged by wholesalers, but Mr Manukyan said those found to be responsible for the increase would be punished. He added that drug prices in Armenia are now higher than in Russia, Germany and France. Pharmaceuticals are Armenia's third most valuable import commodity, but it is reported that no drugs were imported in December.
Meantime, a bill to be submitted to Parliament by April 1 will allow the most needy to get their drugs reimbursed from receipts from VAT on medicines.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze